4.5 Article

Essential Role for Protein Kinase Cζ in Oleic Acid-Induced Glucagon-Like Peptide-1 Secretion in Vivo in the Rat

期刊

ENDOCRINOLOGY
卷 152, 期 4, 页码 1244-1252

出版社

ENDOCRINE SOC
DOI: 10.1210/en.2010-1352

关键词

-

资金

  1. Canadian Diabetes Association [2973]
  2. Natural Sciences and Engineering Research Council of Canada
  3. Banting and Best Diabetes Centre, University of Toronto
  4. Deutsche Forschungsgemeinschaft (the German Research Foundation)
  5. Canadian Association of Gastroenterology (Oakville, Ontario, Canada)
  6. European Foundation
  7. Canada Research Chairs Program
  8. DC5 Biopharma Group
  9. Reddy's Laboratories
  10. Forest Laboratories, Inc.
  11. Johnson Johnson
  12. Merck, Sharp, Dohme
  13. Regeneron

向作者/读者索取更多资源

Luminal monounsaturated long-chain fatty acids [e.g. oleic acid (OA)] increase secretion of the incretin, glucagon-like peptide-1 (GLP-1) from the ileocolonic L cell. However, it is not known whether OA ingestion causes a sufficient increase in distal luminal concentrations to directly enhance GLP-1 secretion. Furthermore, we have demonstrated that protein kinase C zeta (PKC zeta) is required for OA-induced GLP-1 secretion in vitro; however, the physiological relevance of this finding remains unknown. Therefore, we have determined luminal OA concentrations in OA-fed rats and examined the effects of direct OA stimulation on GLP-1 secretion using a novel model of intestinal-specific PKC zeta knockdown. Murine GLUTag L cells express numerous fatty acid transport proteins and take up OA in a saturable manner. Oral administration of OA increased the ileal chyme content of OA by 140-fold over 60-120 min (P < 0.05-0.01), peaking at 105 +/- 50 mu mol/g. To evaluate the direct effects of OA on GLP-1 secretion, 125 mMOA was rectally infused into the colon and terminal ileum of rats. Plasma bioactive GLP-1 increased from 20 +/- 6 to 102 +/- 21 pg/ml at 60 min (P < 0.01). However, pretreatment with ileocolonic adenoviral PKC zeta small interfering RNA resulted in a 68 +/- 8% reduction in the GLP-1 response to rectal OA (P < 0.001). The results of these studies indicate that OA levels in the rat terminal gut after oral ingestion are sufficient to induce GLP-1 secretion and that PKC zeta is necessary for the effects of OA on GLP-1 secretion in vivo. PKC zeta may therefore serve as a novel therapeutic target to enhance GLP-1 levels in patients with type 2 diabetes. (Endocrinology 152: 1244-1252, 2011)

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.5
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据